癌症护理连续体
搜索文档
Myriad Genetics (NasdaqGS:MYGN) 2025 Conference Transcript
2025-11-19 03:20
Myriad Genetics (NasdaqGS:MYGN) 2025 Conference November 18, 2025 01:20 PM ET Speaker1All right, good afternoon. I'm Doug Shankle from Wolfe Research. It's my pleasure this afternoon to host Myriad Genetics from the company. We have old friend Sam Raha, Chief Executive Officer, and Ben Wheeler, Chief Financial Officer, who I just had the pleasure of meeting in person for the first time. Welcome to you both, and thank you for being here.Speaker2Thanks for having us, Doug.Speaker0Good to be with you.Speaker1F ...